Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Consulting agrmnt
Appointed director
Employment agrmnt
|
|
Marker Therapeutics, Inc. (MRKR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| Eansor Norman David (Director) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Bought 14,285 shares
@ $17.5, valued at
$250k
Gifted 14,285 shares
@ $0
Gifted 7,142 shares
@ $0
Granted 8,000 options to buy
@ $1.72, valued at
$13.8k
|
|
| 06/08/2023 |
4
| Knobil Katharine (Director) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 8,000 options to buy
@ $1.72, valued at
$13.8k
|
|
| 06/08/2023 |
4
| Wilson John Robert (Director) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 8,000 options to buy
@ $1.72, valued at
$13.8k
|
|
| 06/08/2023 |
4
| ELMS STEVE (Director) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 8,000 options to buy
@ $1.72, valued at
$13.8k
|
|
| 05/11/2023 |
4
| Vera Juan (President and CEO) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.42, valued at
$142k
|
|
| 03/01/2023 |
4
| Hoang Tsvetelina P (VP, Research and Development) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 33,159 options to buy
@ $2.14, valued at
$71k
|
|
| 03/01/2023 |
4
| Koneru Mythili (Chief Medical Officer) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 51,918 options to buy
@ $2.14, valued at
$111.1k
|
|
| 03/01/2023 |
4
| Loiacono Michael (Chief Accounting Officer) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 38,480 options to buy
@ $2.14, valued at
$82.3k
|
|
| 03/01/2023 |
4
| Vera Juan (Chief Scientific Officer & COO) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 46,487 options to buy
@ $2.14, valued at
$99.5k
|
|
| 03/01/2023 |
4
| Szymanska Anna (Vice President, Quality) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 29,947 options to buy
@ $2.14, valued at
$64.1k
|
|
| 03/01/2023 |
4
| Agopyan Nadia (SVP, Regulatory Affairs) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 34,154 options to buy
@ $2.14, valued at
$73.1k
|
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Laskow-Pooley David (Director) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 80,000 options to buy
@ $0.3377, valued at
$27k
|
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| ELMS STEVE (Director) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 80,000 options to buy
@ $0.3377, valued at
$27k
|
|
| 05/26/2022 |
4
| Eansor Norman David (Director) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 80,000 options to buy
@ $0.3377, valued at
$27k
|
|
| 03/28/2022 |
4
| Hoang Peter L. (President and CEO) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 199,094 shares
@ $0
Paid exercise price by delivering 48,376 shares
@ $0.4848, valued at
$23.5k
|
|
| 03/28/2022 |
4
| Vera Juan (Chief Scientific Officer & COO) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 140,823 shares
@ $0
Paid exercise price by delivering 33,465 shares
@ $0.4848, valued at
$16.2k
|
|
| 03/28/2022 |
4
| Kim Anthony H. (CFO) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 150,512 shares
@ $0
Paid exercise price by delivering 36,076 shares
@ $0.4848, valued at
$17.5k
|
|
| 02/22/2022 |
4
| Hoang Peter L. (President and CEO) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 430,000 options to buy
@ $0.46, valued at
$197.8k
|
|
| 02/22/2022 |
4
| Vera Juan (Chief Scientific Officer & COO) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 160,000 options to buy
@ $0.46, valued at
$73.6k
|
|
| 02/22/2022 |
4
| Szymanska Anna (Vice President, Quality) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.46, valued at
$18.4k
|
|
| 02/22/2022 |
4
| Loiacono Michael (Chief Accounting Officer) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 140,000 options to buy
@ $0.46, valued at
$64.4k
|
|
| 02/22/2022 |
4
| Koneru Mythili (Chief Medical Officer) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 160,000 options to buy
@ $0.46, valued at
$73.6k
|
|
| 02/22/2022 |
4
| Kim Anthony H. (CFO) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 160,000 options to buy
@ $0.46, valued at
$73.6k
|
|
| 02/22/2022 |
4
| Hoang Tsvetelina P (VP, Research and Development) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.46, valued at
$18.4k
|
|
| 02/22/2022 |
4
| Garrett Gerald (Vice President, Clinical Ops.) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.46, valued at
$18.4k
|
|
| 02/22/2022 |
4
| Agopyan Nadia (VP, Regulatory Affairs) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.46, valued at
$18.4k
|
|
| 12/09/2021 |
4
| Knobil Katharine (Director) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 125,000 options to buy
@ $1.2, valued at
$150k
|
|
| 06/10/2021 |
4
| Wasserman Frederick Gerald (Director) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 12,658 shares
@ $0 |
|
| 06/10/2021 |
4
| Laskow-Pooley David (Director) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 12,658 shares
@ $0 |
|
| 06/10/2021 |
4
| ELMS STEVE (Director) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 12,658 shares
@ $0 |
|
| 06/10/2021 |
4
| Eansor Norman David (Director) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 12,658 shares
@ $0 |
|
| 06/10/2021 |
4
| Wilson John Robert (Director) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 12,658 shares
@ $0 |
|
|
|
|